PracticeAuditAndersen ‘asked to resign’ drug audit

Andersen 'asked to resign' drug audit

Struggling firm Andersen, has been 'asked to resign' as auditor of drug company Cambridge Antibody Technologies after 'a number of auditors left the firm'.

According to the drugs group, several auditors based at the firm’s Cambridge office quit the firm earlier this year, prompting CAT’s board to reconsider its position.

Andersen had been CAT’s auditor for five years. A spokeswoman for the company, said: ‘We asked the firm to resign after auditors, we had enjoyed good relationships with, left the firm in February.’

The move was announced to the London Stock Exchange, in which Deloitte was announced as Andersen’s replacement.

CAT’s board of directors said it was fully committed to ensuring it’s auditors maintained complete independence and objectivity.

Related Articles

PwC replaces EY as Domino's auditor

Audit PwC replaces EY as Domino's auditor

1d Alia Shoaib, Reporter
The ‘uncomfortable truth’ behind FRC’s Big Four fines recommendations

Audit The ‘uncomfortable truth’ behind FRC’s Big Four fines recommendations

1w Carl Johnson, Stephensons
BDO holds off Big Four to retain top position as AIM auditor

Audit BDO holds off Big Four to retain top position as AIM auditor

1w Alia Shoaib, Reporter
FRC urged to fine Big Four firms penalties over £10m

Audit FRC urged to fine Big Four firms penalties over £10m

3w Alia Shoaib, Reporter
EY to audit Standard Chartered bank

Audit EY to audit Standard Chartered bank

1m Alia Shoaib, Reporter
KPMG replaces PwC as Croda auditor

Accounting Firms KPMG replaces PwC as Croda auditor

2m Emma Smith, Managing Editor
EY fined £1.8m over Tech Data audit

Accounting Standards EY fined £1.8m over Tech Data audit

2m Emma Smith, Managing Editor
Top 50+50: Firms post significant growth in new tax and audit rankings

Audit Top 50+50: Firms post significant growth in new tax and audit rankings

2m Emma Smith, Managing Editor